Evidence map›Paper›PMID 40029807›Full record

ArticleCancer medicine2025

Multidisciplinary clinician perceptions on utility of a machine learning tool (ALERT) to predict 6-month mortality and improve end-of-life outcomes for advanced cancer patients.

Nithya Krishnamurthy, Melanie Besculides, Ksenia Gorbenko, Melissa Mazor, Marsha Augustin, Jose Morillo, Marcos Vargas, Cardinale B Smith

Abstract read
In one paragraph

Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nithya KrishnamurthyInternal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID https://orcid.org/0009-0009-9091-1927
Melanie BesculidesInstitute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ksenia GorbenkoInstitute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Melissa MazorInternal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Marsha AugustinInternal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Jose MorilloInternal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Marcos VargasSUNY Downstate Health Sciences, University College of Medicine, New York, New York, USA.
Cardinale B SmithDivision of Hematology, Medical Oncology and Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Funding

Conduits: Mount Sinai Health System Translational Science HubUL1TR004419 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rosalind J Wright · 2022 to 2026
$46.4M
Machine Learning to Predict Mortality and Improve End-of-Life Outcomes among Minorities with Advanced CancerR56CA267957 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SMITH, CARDINALE B · 2022 to 2022
$300k
Clinical and Translational Science Awards (CTSA) UL1TR004419NCATS NIH HHS UL1 TR004419NCI NIH HHS P30CA19652NCI NIH HHS R56 CA267957NIH HHS R56CA267957
6 · The paper itself

Abstract

backgroundThere are significant disparities in outcomes at the end-of-life (EOL) for minoritized patients with advanced cancer, with most dying without a documented serious illness conversation (SIC). This study aims to assess clinician perceptions of the utility and challenges of implementing a machine learning model (ALERT) to predict 6-month mortality among patients with advanced solid cancers to prompt timely SIC.

methodsOne-on-one semi-structured interviews were conducted with oncology physicians, advanced practice providers, registered nurses, and social workers until knowledge saturation was reached (N = 19). Thematic analysis was conducted on the transcribed interviews, which were reviewed and coded by a team of interdisciplinary investigators.

resultsClinician-perceived benefits were (1) guiding prognostication and the objectivity of the prediction easing clinician distress with EOL treatment planning; (2) standardizing prognosis discussions across specialties, limiting aggressive EOL procedures; (3) respecting patient values by providing them time to get affairs in order and plan for cultural EOL rituals; and (4) facilitating earlier SIC and palliative care referrals. Challenges identified were (1) integration of predictions with clinical expertise; (2) balancing the reliability and accuracy of the model with a rapidly evolving therapeutic landscape; and (3) concern about patient distress due to poor communication.

conclusionsClinicians expressed widespread acceptability of ALERT and identified clear benefits, particularly in triggering earlier SIC and standardizing prognosis discussions across care teams to avoid aggressive hospital interventions at EOL. Challenges identified, including concerns regarding communication of the prediction and integration with clinical expertise and new research, will guide refinement of the ALERT model.

Indexed as

Attitude of Health PersonnelMachine LearningNeoplasmsTerminal CareAdultFemaleHumansMaleMiddle AgedPalliative CarePrognosiscancer managementclinical managementpredictive modelquality of life

Identifiers

PMID40029807
PMCPMC11875110

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.